Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Multiple Endocrine Neoplasia Type 1 5Neoplasms 2Skin Neoplasms 1Rosacea 1Psoriasis 1Pregnancy Complications 1Neurologic Manifestations 1Motor Activity 1Metabolic Diseases 1Melanoma 1Inflammation 1Feeding Behavior 1Esophageal Neoplasms 1Endocrine System Diseases 1Diabetes Mellitus 1Dermatitis, Atopic 1Colorectal Neoplasms 1Cerebrovascular Disorders 1Cardiovascular Diseases 1

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21Specimen Handling 20CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Melanoma × Eating × Clear all
NCT03253666 2020-07-15

Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)

Harvard School of Public Health (HSPH)

Completed
173,229 enrolled
Dermatologic

Dermatitis, Atopic, Melanoma, Psoriasis, Rosacea, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡